IFNA1 and Schwartz-Jampel syndrome: Although the role of systemic corticosteroids in the treatment of TEN/SJS is controversial, they have been shown to be useful for preventing inflammation in the early stages of the disease and to reduce some biomarkers of inflammation (IFN-IL-6) in TEN/SJS[28].To benefit from this effect, we gave steroids to all our patients.